Orthopedics > OCOSH Classification > Joint Diseases > Arthritis > Gout > Gouty Arthritis > Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

< Previous | Next >

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

Visit Resource Review It Rate It Bookmark It

Location: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC116444/

Description: Objective To assess the safety and efficacy of etoricoxib, a selective cyclo-oxygenase-2 inhibitor, in comparison with indometacin in the treatment of acute gouty arthritis.
Conclusion Etoricoxib 120 mg once daily provides rapid and effective treatment for acute gouty arthritis comparable to indometacin 50 mg three times daily. Etoricoxib was generally safe and well tolerated in this study.
Schumacher et al BMJ. 2002 June 22; 324(7352): 1488–1492. full text

Type: Reference Material
Author/Contact: Schumacher et al
Institution: BMJ
Primary Subject/Category:

Language: English

Submitted by: admin
Hits: 633
Added: Wed Oct 21 2009